Jon Mogford

Jon Mogford

Founder at Safi Biosolutions, Inc.

56 year
Health Technology
Consumer Services
Government

Profile

Jon Mogford is the founder of Safi Biotherapeutics, Inc. (founded in 2019) and serves as the Chairman.
He is currently the Director at The Research Valley Partnership, Inc. and holds the title of Vice Chancellor-Research at Texas A&M University since 2013.
Dr. Mogford has previously served as an Independent Director at RegenETP, Inc. from 2017 to 2020, Deputy Director-Defense Sciences Office at US Defense Advanced Research Projects Agency from 2010 to 2011, Independent Director at Innoveren Scientific, Inc. from 2016 to 2018, and Assistant Professor & Research Associate at Northwestern University from 1998 to 2003.
He has an undergraduate degree from Texas A&M University and a doctorate degree from Texas A&M Health Science Center.

Jon Mogford active positions

CompaniesPositionStart
Texas A&M University Corporate Officer/Principal 2011-10-31
Director/Board Member -
Founder 2018-12-31
All active positions of Jon Mogford

Former positions of Jon Mogford

CompaniesPositionEnd
REGENETP, INC. Director/Board Member 2020-07-30
INNOVEREN SCIENTIFIC INC. Director/Board Member 2018-10-14
US Defense Advanced Research Projects Agency Corporate Officer/Principal 2011-09-30
Corporate Officer/Principal 2002-12-31
See the detail of Jon Mogford's experience

Training of Jon Mogford

Texas A&M University Undergraduate Degree
Texas A&M Health Science Center Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jon Mogford's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
REGENETP, INC.

Health Technology

INNOVEREN SCIENTIFIC INC.

Health Technology

Private companies3
US Defense Advanced Research Projects Agency

Government

Commercial Services

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW